Thermo Fisher Scientific has received Good Manufacturing Practice approval from the Italian Medicines Agency allowing the company to manufacture RNA-based products at its Monza, Italy site.
Thermo Fisher Scientific has received Good Manufacturing Practice approval from the Italian Medicines Agency allowing the company to manufacture RNA-based products at its Monza, Italy site.